Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer in the United States, Europe, and Israel

INTRODUCTION: Genetic mutations in breast cancer susceptibility gene 1 or 2 (BRCA1/2) confer a high risk for developing breast cancer; however, at least 50% of women with BRCA1/2 mutations go undiagnosed. This study evaluated differences in patient demographics, clinical characteristics, and BRCA1/2...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahtani, Reshma, Niyazov, Alexander, Lewis, Katie, Rider, Alex, Massey, Lucy, Arondekar, Bhakti, Lux, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859923/
https://www.ncbi.nlm.nih.gov/pubmed/36333567
http://dx.doi.org/10.1007/s12325-022-02302-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859923/
https://www.ncbi.nlm.nih.gov/pubmed/36333567
http://dx.doi.org/10.1007/s12325-022-02302-2

Ejemplares similares